Fermilab to build Illinois Accelerator Research Center

December 16, 2011 | 2:25 pm

From left: Bob Kephart, IARC Project Director; Jim Siegrist, associate director of the Office of Science for the Office of High Energy Physics; Michael Weis, DOE Fermilab site manager for the Office of Science; William Brinkman, director of the Office of Science for the DOE; Pier Oddone, Fermilab director; Warren Ribley, director of the Illinois Department of Commerce and Economic Opportunity; Linda Holmes, Illinois state senator; and Michael Fortner, Illinois state representative. Image by Reidar Hahn, Fermilab

Fermi National Accelerator Laboratory issued the following press release today.

Batavia, Ill. – A new accelerator research facility being built at Fermi National Accelerator Laboratory will bolster Illinois’ reputation as a technology hub and foster job creation.

The Illinois Accelerator Research Center (IARC) at the Department of Energy’s Fermilab will provide a state-of-the-art facility for research, development and industrialization of particle accelerator technology. The design and construction of IARC is jointly funded by DOE and the State of Illinois.

“In Illinois we understand the importance of investing in cutting edge technologies, which not only boost our economy, but also secure our role as a major competitor in the global marketplace,” said Governor Quinn. “The best minds in the world are right here, and today we are investing in our future by ensuring that the latest groundbreaking particle research activities will continue to come from Illinois.”

A major focus of IARC will be to develop partnerships with private industry for the commercial and industrial application of accelerator technology for energy and the environment, medicine, industry, national security and discovery science. IARC will also offer unique advanced educational opportunities to a new generation of Illinois engineers and scientists and attract top scientists from around the world.

Located in the heart of the industrial area of the Fermilab campus, IARC will house 42,000 square feet of technical, office and educational space for scientists and engineers from Fermilab, DOE’s Argonne National Laboratory, local universities and industrial partners.

“The IARC facility will help fuel innovation by developing advanced technologies, strengthening ties with industry and training the scientists of tomorrow,” said Dr. William F. Brinkman, Director of DOE’s Office of Science, one of the speakers at today’s groundbreaking. “The Department of Energy welcomes the opportunity to partner with the State of Illinois and looks forward to seeing IARC come to fruition.”

“In Illinois we understand the importance of investing in cutting edge technologies, which not only boost our economy, but also secure our role as a major competitor in the global marketplace,” said Governor Quinn. “The best minds in the world are right here, and today we are investing in our future by ensuring that the latest groundbreaking particle research activities will continue to come from Illinois.”

A major focus of IARC will be to develop partnerships with private industry for the commercial and industrial application of accelerator technology for energy and the environment, medicine, industry, national security and discovery science. IARC will also offer unique advanced educational opportunities to a new generation of Illinois engineers and scientists and attract top scientists from around the world.

Located in the heart of the industrial area of the Fermilab campus, IARC will house 42,000 square feet of technical, office and educational space for scientists and engineers from Fermilab, DOE’s Argonne National Laboratory, local universities and industrial partners.

“The IARC facility will help fuel innovation by developing advanced technologies, strengthening ties with industry and training the scientists of tomorrow,” said Dr. William F. Brinkman, Director of DOE’s Office of Science, one of the speakers at today’s groundbreaking. “The Department of Energy welcomes the opportunity to partner with the State of Illinois and looks forward to seeing IARC come to fruition.”

Press Release

No Comments »

Kicking cancer with carbon ions

December 14, 2011 | 7:15 am

Hadron therapy patients receive treatment in this room at CNAO in Italy. Image courtesy of CNAO

Medical physics is getting heavier. Shooting intense beams of protons into tumors to destroy them while leaving nearby tissues largely unharmed has been in vogue since the ’60s. Globally, however, many centers offering such beam-based cancer treatment, known as hadron therapy, are looking to more massive carbon ions for their unique therapeutic promise. These particles are sometimes able to eradicate tumors that have become resistant to all other forms of radiation.

One interested center is CNAO, an Italian acronym that stands for the National Centre for Oncological Hadron Therapy. On Sept. 22 the facility finished treating its first cancer patient with proton beams and plans to be ready for carbon-ion beams by mid-2012.

“You don’t build such a giant center just for protons,” CNAO technical director Sandro Rossi said. When all the magnets needed to steer the large carbon ions from the hospital’s basement accelerator to the patient are installed, the apparatus will weigh between 1,000 and 2,000 tons. Rossi expects that, in the next decade or so, when the facility is fully operational, 80 percent of its treatments will be with carbon ions, the rest with protons.

The design for the synchrotron accelerator now used at CNAO originated in a study done at CERN from 1995 to 2000. The European laboratory then provided help with key systems of the machine, and experts still share their advice as needed, though none are employed by the medical center.

Both protons and carbon ions offer precision and damage-control advantages over other radiation therapy. Traditional radiation therapy and chemotherapy target a greater portion of the body than hadron therapy, leading to undesirable extra damage and side effects. Due to an energy distribution known as the Bragg peak, protons and carbon ions can be made to deliver the bulk of their impact at a particular depth within tissues: Tumors are pounded while surrounding tissues are largely left alone. Proton beams are so precise that they are often used when tumors lie close to vital organs and surgery is too risky an option.

This synchrotron accelerator provides particles for hadron therapy at CNAO. Image courtesy of CNAO

But while protons may only damage one strand of DNA in a tumor cell, eventually causing its death, carbon ions cripple both strands in the double helix. Thus the heavier carbon ions make a more potent beam and have a better chance to kill cells traditional methods haven’t been able to.

Still, clinical tests of carbon ion therapy remain scanty. Only 6,000 to 7,000 patients in history have been treated this way, which is few in terms of medical statistics for such a procedure, Rossi said. Japan, the world leader in carbon ion treatment, is responsible for more than 90 percent of these patients. Rossi expects that CNAO will begin regular treatments with proton beams at the end of next year and with carbon ion beams some months later, after more trials are complete.

Meanwhile in the U.S., the Mayo Clinic broke ground on its second proton beam facility in Arizona on Tuesday. Only nine other proton centers in the nation are currently operational, though seven more are in development.

“Right now we’re just trying to get our heads around the protons,” said Chair of Radiation Oncology at the Mayo Clinic in Arizona Steven E. Schild about the Arizona facility. No carbon ion treatment centers exist yet in the U.S., though Schild said they’ve been thinking of adding that technology at the Mayo Clinic.

While hadron therapy is the most promising form of radiation available, he can’t be positive this is the future of cancer treatment, he said. “We’ll see.”

Part of Schild and other U.S. proton pioneers’ research will involve cost-benefit analysis of such beam centers, including those that use carbon ions, to see if the initial expenses are ultimately outweighed by the decrease in complications, secondary effects and tumor recurrence using this method. “What you want to accomplish is the greatest good for the most people,” he said.

Amy Dusto

No Comments »

Physicists talk turkey

November 23, 2011 | 11:46 am

Looking for some help with cooking your Thanksgiving feast this holiday? Here are a couple of ways that particle physics can lend a hand.

The plastic industry uses particle accelerators to treat the sturdy shrink wrap that keep Butterball turkeys and many other food products fresh.

Not sure how long to cook your turkey? Take some advice from SLAC Director Emeritus Pief Panofsky and use the equation he derived for the holiday: = W(2/3)/1.5, where t is the cooking time in hours and W is the weight of the stuffed turkey, in pounds. The constant 1.5 was determined empirically.

If a Butterball turkey will take the spotlight on your table, you have particle accelerators to thank for its freshness. The food industry uses particle accelerators to produce the sturdy, heat-shrinkable film that Butterballs come wrapped in. When a beam of electrons from a particle accelerator hits the plastic wrapping, it causes a chemical reaction that makes the film super strong and heat resistant. The food industry purchases the treated shrink wrap from plastic manufacturers in the form of bags or rolls. A turkey gets placed inside, and voila, a fresh meal will soon grace your Thanksgiving table.

From all of us at symmetry magazine, have a wonderful Thanksgiving!

Elizabeth Clements

No Comments »

The multiplying effects of an accelerator economy

November 7, 2011 | 4:13 pm

ILC NewsLine first published this story on Nov. 3 2011. 

On the homepage of a US-based company website is a picture that, at first glance, looks like an advertisement for a major household appliance. A yellow starburst graphic assures you that delivery time is quick. A text-boxed baseline price is presented in glowing type. And at the centre is the touted item: an ILC/TESLA-type accelerator cavity.

Image of Niowave's website. Image: Niowave

Through the ad, Niowave, Inc., a superconducting linear accelerator company based in Lansing, US, showcases its capability for producing cavities with relatively short turnaround times. For the accelerator community, the ad could be a sign that the production of these superconducting structures is very slowly inching its way towards a place in the market as an in-stock product.

“It’s an indication of their confidence in this product as a catalog item,” said Global Design Effort Project Manager Marc Ross. “It means there’s somebody there willing to buy a number of them in that way.”

Niowave is one of several US companies developing superconducting technology for the ILC. To weld its cavity cells together, it relies on C.F. Roark, a partner company in Indianapolis, US.

It’s too early to predict how well cavities will do in the market as a prefabricated good, but Terry Grimm, who started the company in 2005 and worked extensively with particle accelerators as a laboratory and university physicist, knows there’s a niche for them outside high-energy physics.

“We see a real opportunity here – there’s a commercial market out there for these devices,” Grimm said. The devices aren’t necessarily for large, underground high-energy particle colliders. Plenty of biology and defense projects make use of tabletop accelerators that use similar technology as that for the ILC. “Going into the commercial market, we can talk about those smaller machines.”

Cavities for the ILC are a much taller order than those for commercial projects. The niobium is purer, the gradients are higher and the basic structures have complicated add-ons. Commercial projects don’t require as much of their cavities. But in the course of developing state-of-the-art niobium structures, you learn a few things that can only help when manufacturing simpler systems.

“That work could work out well for them, even for the sake of the technology, not just the company,” Ross said.

For Niowave, developing the technology isn’t just about maximising gradients. It also means perfecting a basic, so-called Entry Level model of superconducting cavity, much like the no-frills Chevrolet. This 20 megavolt-per-metre cavity can be produced at a significantly lower cost than the ILC’s 35 MV/m ‘Cadillac’ standard model, and since many of the company’s customers don’t need the highest possible gradients, the Entry Level could go over well with a fair share of their clients.

Niowave sees enough of a market that it stockpiles raw niobium so that it’s within arm’s reach, ready to be treated and shaped when an order comes in. It’s the only company in the world that can make that claim. Being able to pull niobium off the shelf is the convenient first step in an operation that develops turnkey accelerator systems, including cryogenics and beam testing. Conveniently, the company has a radiation generating license that allows them to conduct beam tests, something that’s otherwise reserved for laboratories.

Developing such systems is a relatively young enterprise for industry in the US.

“In the US, the niobium cavities were made at the laboratories themselves. That’s part of why it’s such a new business for industry,” Grimm said. “That’s where the ILC has been very helpful – getting industry and the labs working together. The ILC community keeps pushing for more work in that area.”

Niowave is housed in a former elementary school in Lansing, Michigan. The research and development of superconducting accelerators takes place in classrooms, offices and lounges – even in the boiler room. The name Niowave is a combination of ‘niobium’ and ‘microwave’. Image: Niowave

Other fields seem to be feeling the effect of the push. Niowave’s free-electron laser systems can help see through a cargo container that might be carrying illegal weapons materials. The company is also developing superconducting cavities for electron microscopes in which the high-frequency pulsed electron beam would make it possible to image a series of snapshots in a chemical reaction. There, researchers hope to be able see the chemical reactants transform into products in front of their eyes.

“Some of the scientists that are developing and using electron microscopes come to us. They have some of the things we need, but they have very little experience with microwaves and accelerating cavities,” Grimm said. “That’s where we come in.”

The same push to make better superconducting linacs has also been felt in the Lansing region’s economy, best known for automobile manufacturing. Also, Michigan State University, home of the National Superconducting Cyclotron Laboratory and future Facility for Rare Isotope Beams (FRIB), is a hub of atomic and particle physics expertise. A recent renewal of high-technology manufacturing has brought life to an area hit hard by the 2008 recession.

The multiplier effect, said Bob Trezise, CEO of Lansing Economic Development Corporation, is significant.

“This has certainly been true with Niowave, where almost all of its sales originate from customers outside of Michigan,” he said. “By combining the research at the new FRIB project and the commercialisation efforts of FRIB’s research at Niowave, mid-Michigan has established itself as a worldwide powerhouse for the superconducting accelerator industry.”

While reaching out to other areas of exploration, Niowave will continue developing cavities for the ILC.

“They have the opportunity to show that there’s a small business model for this technology,” Ross said.

Leah Hesla

No Comments »

The Tevatron: a training ground beyond particle physics

October 25, 2011 | 8:41 am

Beyond smashing together billions of protons and antiprotons over the course of its 28 years of operations, Fermilab’s Tevatron also served as a launching pad for many careers, often in fields beyond particle physics.

Ron Moore now helps operate the 17 MeV cyclotron at Mass General Hospital. The accelerator produces radioisotopes used for medical diagnosis.

Take Ron Moore, the former head of Fermilab’s Tevatron Department, for example.

This month, Moore is starting a new endeavor as a medical physicist with a joint appointment at Harvard University and Massachusetts General Hospital in the Nuclear Medical & Molecular Imaging Division of the Department of Radiology. In his new role, he will help run a 17 million electronvolt (MeV) accelerator that makes radioisotopes used for medical diagnosis, such as PET scans, and conduct research about new imaging techniques.

Besides leaving the picturesque cornfields of Illinois for the collegiate charm of Boston, Moore realizes that he will have a few adjustments to make after working with the world’s largest proton-antiproton accelerator for the past 10 years.

“For starters, I can practically put my arms around the accelerator at Mass General,” Moore says with a grin.

Cutting your teeth on a machine like the Tevatron, however, prepares you for just about anything an accelerator might throw at you—no matter its shape, size or function.

“At Fermilab, you learn lots of accelerator skills because running a complex machine like the Tevatron is not trivial,” says Roger Dixon, head of Fermilab’s Accelerator Division. “Ron saw the technical problems, and he saw the solutions. That particular skill applies anywhere.”

The application
At 4 a.m. every morning, the accelerator at Mass General begins operating to produce Flourine-18, Carbon-11 and Nitrogen-13, the three main isotopes that the hospital uses. Once the accelerator makes the isotopes, they get transported through a pipeline in the hospital to the chemistry lab where chemists prepare them for the specified medical procedure. The isotope is then transported to imaging, where it will either get injected into the patient’s bloodstream or inhaled as part of a gas.

Mass General is currently one of 300 hospitals in the United States that has an in-house accelerator to produce medical isotopes for diagnostic procedures, including bone scans, gastrointestinal studies and cancer detection. Medical physicists like Moore keep the accelerators running on a daily basis in order to supply the hundreds of medical isotopes that are needed for patients every day.

“You’re running the accelerator every day for patients. Uptime is very important,” Moore says. “The focus is on running and not to set a record store, like it was at the Tevatron.”

When inside the human body, the isotope emits positrons—the opposite of electrons. When a positron hits an electron, it gives off energy and a detector tracks its movement and location to create an image that doctors use to diagnose disease and select effective treatments. Different isotopes have different purposes, and chemists can combine them with substances that aid in the diagnostic process.

When looking for a tumor, for example, chemists will combine Flourine-18 with a sugar to make the isotope go to areas of high metabolism in the patient. Because tumors have very high rates of metabolism, Flourine-18 laced with sugar will go right to that spot and illuminate it.

Prior to joining Mass General, Ron Moore was the head of the Tevatron Department at Fermilab.

The runner
Moore first became interested in medical physics when he needed to have a bone scan last December.

An avid runner, Moore started experiencing chronic pain in his shin. With the help of an isotope, a bone scan revealed the source of his pain—a small fracture in his tibia.

“I have always been interested in medical applications and how accelerators can be used for direct benefits for society,” Moore says.

A longtime member of the CDF experiment at Fermilab, Moore also brings decades of particle detector experience to Mass General and will work on medical imaging research.

For example, the medical physics community is actively working to develop real-time imaging using PET scans during proton cancer therapy treatments. Moore hopes to apply his background in high-energy physics detector development and electronics to the real-time imaging efforts.

And now that Moore’s tibia is all healed, when he isn’t running the accelerator, he’s hoping to find time to run along the banks of the Charles River, getting to know his new town.

Elizabeth Clements

2 Comments »

SLAC physicists using physics simulation tool to make cancer therapy safer

October 24, 2011 | 4:45 pm

This story first ran in SLAC Today on Oct. 20, 2011.

Joseph Perl described how he and his colleagues are turning the simulation toolkit Geant4 into a powerful application for medical physicists. Image by Helen Shen.

Tiny particles are making a big difference in the world of cancer therapy. And SLAC physicists—experts in particle transport—are using computer simulations to make those therapies safer.

At the Oct. 10 SLAC Colloquium, the lab’s own Joseph Perl described how he and his colleagues are turning the simulation toolkit Geant4 into a powerful application for medical physicists. Originally designed to track subatomic particles in high-energy physics experiments, Geant4 can also map proton paths through patients’ bodies during radiation treatment.

In radiation treatment, subatomic particles inflict DNA damage on dividing cells—both healthy and cancerous—causing them to commit suicide. The technique works because rapidly growing cancer cells are more likely to be dividing at any given time, and thus are more likely to be killed; but a smaller proportion of healthy cells are also susceptible to damage.

Minimizing collateral damage is a tough problem for medical physicists who design radiation treatments.

“To perfect this stuff, what we have to understand really is where are the particles going?” Perl said. “We have to understand particle transport when we’re designing the medical linacs,” the accelerators that deliver the particles to patients. “We have to understand particle transport when we’re talking about how the beams actually penetrate the body.”

Computer simulation tools such as EGS4, developed at SLAC in the 1970s, have helped medical physicists predict the behavior of X-rays and gamma rays. Now, Geant4 offers the ability to model proton beams, too.While Perl is SLAC’s only Geant4 team member working on medical physics applications, he works with four other partners on more general Geant4 capabilities. Together they constitute the second-largest team in the international Geant4 collaboration.

In contrast to the X-ray beams used in traditional therapies, which go all the way through the body, proton beams dump their energy at a specific depth. Medical physicists can target a tumor at one depth and avoid deeper and shallower tissues by tweaking the energy levels of one or more beams. Proton beam therapy may be particularly useful in children, for whom stray radiation can stunt growth and cause secondary cancers in adulthood.

Geant 4 relies on a technique called Monte-Carlo simulation, which models each proton moving through the body in a series of random steps. At each step, the program essentially casts a die to guess where the particle will move next. Over many steps, the program shows where protons are most likely to end up.

Unlike many other tools, Geant4 can also simulate the effect of tissues, such as the rib bones, that may move in and out of the proton beam as a patient breathes. Such obstructions can block some radiation from the intended target, while simultaneously allowing some tissue to soak up unnecessary radiation. Geant4 can potentially help medical physicists program beams to track a moving target and deliver a constant dosage to the tumor.

Geant4 is freely available to anyone who wants to use it, but in its current form may be challenging to some novices. “It’s a really fancy techno-Lego kit,” said Perl, but the box does not come with any ready-made toys.

To address this problem, SLAC’s Geant4 team has joined Massachusetts General Hospital and the University of California-San Francisco, in a four-year collaboration funded by the National Institutes of Health. The project, headed by Perl, will help medical physicists customize their simulations without disrupting the program’s innermost workings.

“If we can make it easier for people to use,” Perl said, “the more likely they are to use things right.”

- Helen Shen

Symmetry Intern

No Comments »

Advancements in proton therapy cause for celebration

October 21, 2011 | 9:43 am

This article first appeared in Fermilab Today on Oct. 21, 2011.

A fully commissioned and operational gantry room. Image courtesy of ProCure Proton Therapy Centers

In 1946, founding Fermilab director Robert Wilson was one of the first to tout the benefits of proton therapy. The cancer treatment has since been lauded as a way to minimize damage to healthy tissue while focusing a finely calibrated beam directly on the tumor – an impossibility for radiation treatments based on X-rays or gamma rays. Yet protons were not used within a hospital facility until 1990 with Fermilab’s construction of a particle accelerator at Loma Linda University Medical Center. Since then, the industry has grown and the technology has evolved. Worldwide, 37 centers use proton therapy and more than 73,000 patients have been treated.

The ProCure facility in nearby Warrenville, Ill., one of only nine centers in the U.S., is completing its first year of proton therapy. The facility uses an accelerator called the Cyclotron to administer the proton therapy. One distinction that sets the Cyclotron apart from other accelerators is that the particles are sped up to just 230 MeV, an energy high enough to treat tumors as deep as 32 cm within a patient.

The proton therapy process begins with the transformation of hydrogen gas into plasma. The Cyclotron speeds up the particles and isolates the protons along a curve of magnets that lead to one of four rooms within the treatment center. With the aesthetics of a set piece from “2001: A Space Odyssey,” a large gantry device rotates the beam line on a track and the patient, lying on a platform, is precisely positioned by a large robotic arm similar to ones used in automotive manufacturing. Here the proton beam is slowed to an energy that will reach the tumor and be absorbed by the cancer cells but go no further, while a brass aperture on the nozzle narrows the beam into the shape of the tumor. For the beam to be a precise match to the tumor, the aperture is designed for each individual patient.

Mingcheng Gao worked with DZero as the detector went operational and is thrilled to use the skills he gained at Fermilab as a senior medical physicist at the ProCure facility.

“The technology is advancing quickly,” he said.

The price of building and running each proton therapy center has been the field’s greatest hindrance for decades. After 22 months of construction, the ProCure center ultimately cost $150 million to build. Yet with the increasing demand for proton therapy, Gao sees proton treatments playing a larger role in fighting cancer.

“The cost will definitely go down in the future,” he said.

Brad Hooker

3 Comments »

Mirrors harness X-rays for science

October 17, 2011 | 9:09 am

SLAC first published this article on Oct. 11, 2011.

Up close, they look simple as can be: a pair of metal bars, each with one side polished to a brilliant shine. One bar faces up, the other to one side.

A K-B mirror system consists of two curved mirrors placed at right angles to each other. A parabolic mirror shape will focus a collimated beam to a point, while an elliptical mirror shape will focus a point to another point.

They’re known as K-B mirrors, sophisticated X-ray focusing tools that have a pedigree going back to the very birth of X-ray microscopy. The shiny sides can be within a nanometer of being perfectly smooth, are exquisitely shaped into a barely perceptible curve of an ellipse, and may have one or more atomically precise coatings of exotic elements like platinum or rhodium.

The “B” in K-B mirrors stands for Albert Baez, father of folk singer Joan Baez, who helped invent this ingenious focusing system in the late 1940s while a graduate student at Stanford University. The “K” is for his Ph. D. advisor and co-inventor Paul Kirkpatrick, then head of the physics department.

Their invention signaled the beginning of X-ray optics – the ability to manipulate X-rays, an energetic, penetrating form of light. Today, thousands of scientists worldwide use X-ray beams to examine the material world in atom-by-atom detail, fueling advances in energy production, electronics, environmental cleanup, new materials, nanotechnology, medicine and many other fields.

“All these years later, K-B mirrors have become an essential tool for focusing X-rays to the tiny spots that scientists need for their experiments,” said Piero Pianetta, Stanford Synchrotron Radiation Lightsource deputy director. “Between SSRL and the Linac Coherent Light Source, we have about a dozen of these mirror systems here at SLAC.”  The world’s most accurate K-B mirror system currently in use, which was recently installed at LCLS, cost $1.2 million, when all of its alignment and stability aids are figured in.

For more than 50 years after Wilhelm Röntgen discovered X-rays in 1895, no one had figured out a way to focus this mysterious, penetrating form of light. Röntgen himself had proclaimed that it would be impossible to focus X-rays with lenses. In 1922, Arthur Compton reflected X-rays from polished surfaces at “grazing” or “glancing” angles of one degree or less. There matters sat for more than two decades, when Kirkpatrick began to explore the possibility of using Compton’s technique to focus X-rays.

Reflecting light with a single curved mirror produces a severe astigmatism, focusing rays from a point source to a line. “It was Kirkpatrick’s idea that a second curved mirror placed at a right angle to the first would ‘squeeze’ that line down to a point,” Baez said later in several retrospective articles and talks. He had been teaching calculus at Stanford and also working as a lab assistant in the Physics Department when Kirkpatrick asked if he’d like to work under him as a graduate student to develop this idea.

“I jumped at the chance,” Baez recalled.

In a historic 1948 paper, Kirkpatrick and Baez introduced their mirror pair as part of the world’s first X-ray microscope. But it would be another quarter century before three other developments enabled scientists to use the mirrors productively: In the mid-1970s, machining, polishing and metal-coating techniques improved enough to make ultra-smooth surfaces that could reflect X-rays without significant scattering. Second, James Underwood, an X-ray optics pioneer who later worked at Stanford, showed how to flex the mirrors precisely into the elliptical shapes that eliminated unwanted optical aberrations. Thirdly, new X-ray sources called synchrotrons produced intense beams of X-rays for probing and unlocking the secrets of molecules and materials.

With more than 70 synchrotron light sources now operating or under construction around the world, K-B mirrors are made by six manufacturers: two in France and one each in Germany, Japan, the United Kingdom and United States. There are several other ways to focus X-rays, but these mirrors are popular because unlike technologies based on diffraction or refraction, they reflect most  X-ray energies approximately uniformly.

LCLS mechanical engineer Jean-Charles Castagna (foreground, right) and Dan Harrington, SSRL engineering physicist, stand by the K-B mirror system at the Stanford Synchrotron Radiation Lightsource. Their hands are resting on the chambers that hold the actual mirrors. Photo by Mike Ross.

Despite their simple design, crafting K-B mirrors has become much more complicated over the years. The first K-B mirrors were made of glass or quartz coated with a reflective metal film. Today’s mirrors are typically made from silicon crystals polished to near-atomic smoothness and then coated with ultra-thin layers of hard silicon carbide or dense metals. The shorter the X-ray wavelength being focused, the more precise the mirror surface must be.

“The mantra for X-ray mirror designers is ‘figure and finish,’” said Underwood. “Figure is the shape of the mirror and finish is its surface roughness. Many innovations over the years have improved our ability to make more accurate focusing figures and smoother mirror finishes.”

The mirror surface must be formed – or flexed – into the correct curved shape to focus the beam. This can be done in several ways. Most often, the mirror surface is polished while flat and then positioned in the beamline, supported on both ends. Then, an actuator motor applies a bending force near each end of the mirror, flexing the mirror into an ever-so-slight concave shape. Controlling the placement and amount of the force, as well as the mirror block’s shape and its supports, determines the resulting curve.

“For point-to-point focus you need an elliptical mirror shape,” said SSRL engineering physicist Tom Rabedeau. “Focusing a collimated beam to a point or vice versa requires a parabolic mirror shape.”

The mirror has to keep that shape despite being pummeled with intense high-energy X-rays. Although the X-rays are supposed to reflect off the mirror at a glancing angle, some of their energy is inevitably absorbed by the mirror, and the resulting heat buildup can warp or otherwise distort it.

The high energies of the X-ray laser pulses at the LCLS can also cause ablation, ejecting atoms from the mirror surface and reducing focus quality. Coatings can help minimize such damage. And while the mirrors are usually held in a vacuum, stray molecules owing to imperfect vacuum may stick to the mirror surface,  degrading its focus.

Temperature fluctuations can deflect the mirrors’ focal point. And when using long mirrors, designers even have to account for sagging between the mirror’s end supports due to gravity, said Nicholas Kelez, LCLS mechanical engineer. Jitter in the actual location of the X-ray beam also affects its ultimate focus.

“K-B optics are nice, since you can adjust one axis at a time,” Rabedeau said. But even a tiny error in the adjustment can throw the beam’s focus way off. For a one-meter-long mirror, “a one-micron mirror deflection means a huge 60-micron move in the focus spot 30 meters distant,” he added. Increasingly, researchers are using automatic sensor-feedback “servo” controls to fine-tune the positions of the mirrors to keep the X-rays focused accurately onto their target.

“All in all, K-B mirrors give you much better control of the focused spot shape than other X-ray focusing methods,” said Dan Harrington, SSRL engineering physicist.

The world’s best K-B mirror system currently in use is in LCLS’ Coherent X-ray Imaging (CXI). Its $300,000 mirrors were made in Japan using a precision liquid-jet method to shape the desired elliptical figure directly into the silicon, avoiding the need for mirror-bending apparatus. Each of the 350 mm-long reflecting surfaces are smooth to better than 1 nanometer surface roughness over their entire length.

A German company then built the mirrors’ enclosure, alignment system and 6-ton granite base, bringing the total price tag of $1.2 million. It can focus to a one-micron spot, and its focal plane can be moved by about half a meter to accommodate the needs of various experiments, said Sebastien Boutet, CXI instrument scientist.

CXI’s current K-B system won’t be the star of the show very much longer, however. A near-twin of that system, designed to focus the LCLS pulses down to much smaller 0.1-micron-diameter spots, has been built in Japan and is being commissioned now in Germany. Installation should begin at CXI next month.

- Mike Ross

 

Guest author

No Comments »

Particle accelerators used to compile nutritional database in Sudan

September 12, 2011 | 4:41 pm

Forty-one percent of the children in Sudan are malnourished and underweight, according to the Food and Agriculture Organization of the United Nations. Mohamed Eisa, a physicist at the Sudan University of Science & Technology, would like to change this statistic, and he believes that particle accelerators can help.

Maps of sulphur and calcium in a hair cross-section for a typical Sudanese (left) and South African (right). Sulphur appears to be distributed similarly.

By using the powerful beams of a proton accelerator, Eisa is analyzing the elemental composition of hard human tissues, such as kidney stones, hair and teeth from all regions in Sudan. His plan is to investigate and determine the levels of calcium, phosphate, iron and other elements in the samples and use the information to create a database that records nutritional deficiencies in the country.

“Sudan is a country of civil war for a long time, and this results in many problems, such as poverty and lack of main services like clean water and medical care,” Eisa says. “This is reflected on the lives of citizens in those affected areas, and I would like to have more focus on these problems to help the development and stability of those affected areas.”

Eisa started using accelerators to analyze samples about ten years ago when he was a graduate student at the iThemba Laboratory for Accelerator-Based Science and Cape Town University in South Africa. He uses a specialized technique called a nuclear microprobe.

In the accelerator, each sample gets exposed to a low-energy proton beam. The protons cause the sample to emit X-rays with wavelengths specific to a particular element. Eisa collects the information to analyze the composition of each sample and note deficiencies, such as iron.

“There is a deficiency in iron in most of the Sudanese regions due to diet, as stated by the Food and Agriculture Organization,” he says. “Fifty percent of all the children are anemic particularly at the war regions and rural areas.”

By pinpointing the specific regions of the country where children are lacking iron, for example, Eisa hopes the database will give officials the information necessary to provide nutrients to the areas that need them most.

“The results show a marked difference between the regions due to differences in food availability, climate as well as regional food habits in Sudan,” he says.

Eisa hopes to complete the study in 2012.

The following organizations have supported his work: iThemba LABS and the iThemba Collaboration in South Africa, Sudan University of Science and Technology, and the Third World Academy of Science – United Nations Educational, Scientific Cultural Organization (TWAS-UNESCO).

 

Elizabeth Clements

No Comments »

Beams to order from table-top accelerators

August 26, 2011 | 3:50 pm

Berkeley Lab published the following story on August 22, 2011. For more about table-top accelerators, read Crashing the Size Barrier in symmetry magazine.

A laser pulse through a capillary filled with hydrogen plasma creates a wake that can accelerate an electron beam to a billion electron volts in just 3.3 centimeters. The same LOASIS accelerating structure has been modified to tune stable, high-quality beams from 100 to 400 million electron volts. (Photos by Roy Kaltschmidt, Berkeley Lab Public Affairs)

Laser plasma accelerators offer the potential to create powerful electron beams within a fraction of the space required by conventional accelerators – and at a fraction of the cost. Their promise for the future includes not only compact high-energy colliders for fundamental physics but diminutive sources of intensely bright beams of light, spanning the spectrum from microwaves to gamma rays – a new kind of ultrafast light source for investigating new materials, biological structures, and green chemistry. Compared to today’s giant science facilities, “table-top” laser plasma accelerators may eventually be able to do equally powerful research with minimal environmental impact.

To reach these goals, laser plasma accelerators must be able to produce high-quality, stable electron beams and tune those beams to the users’ needs. The LOASIS program at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) has already demonstrated high-quality beams up to a billion electron volts in a mere 3.3 centimeters; the BELLA project will reach 10 billion electron volts in a single meter.

Now the LOASIS team has demonstrated a simple way to tune highly stable beams through a wide range of energies. They describe their methods in the journalNature Physics.

Surfing the wave

“To describe how a laser plasma accelerator works, I use the analogy of a surfer riding a wave,” says Wim Leemans, who heads the LOASIS program in Berkeley Lab’s Accelerator and Fusion Research Division. “The surfers are the electrons themselves. The waves form when a laser pulse plows through a plasma.”

In a plasma, atomic nuclei (ions) are separated from electrons, and immensely strong electric fields can build up between the oppositely charged particles when they are separated by the waves behind a powerful laser pulse. Some of the electrons in the plasma are swept up by the waves and are quickly accelerated to high energy.

“In this case the wave is a tsunami, and it doesn’t much matter what the surfers do; they’ll be carried along,” Leemans says. “That’s called self-trapping. But there are other ways a surfer can catch a wave. Real surfers can gauge the size and speed of an oncoming wave and start paddling to match its momentum.”

Attempts to create tunable electron beams through momentum-matching have been tried, by injecting electrons into the accelerating field – first giving them a boost using colliding laser pulses to catch the wave, then using a different drive-laser pulse to excite a wave on which those surfing electrons can be accelerated to high energies. It’s an approach that demands sophisticated timing and synchronization, and along with other tuning methods for one-stage accelerators, requires electron injection that’s localized in space and time.

“But there’s a third way of helping a surfer catch a wave,” Leemans says, “and that’s by slowing the wave until even slow surfers can catch it – then increasing the speed of the wave.” In other words, a two-stage process – and this turns out to be the secret to tunable, high-quality electron beams.

For their experiments the Berkeley Lab scientists modified the same 3.3-centimeter LOASIS accelerator and the same 40-trillion-watt peak-power drive laser, dubbed TREX, they used to produce the first billion-electron-volt beam. The accelerator is a block of titanium sapphire with a narrow capillary through it, filled with hydrogen gas that’s ionized to a plasma by a jolt of electricity, just before the drive-laser pulse enters.

“Two-stage” acceleration

Slowing the laser wake and then speeding it up requires controlling the wake’s phase velocity. To modify the LOASIS system for “two-stage,” tunable acceleration, the researchers introduced a supersonic jet of helium gas that passes through the accelerator’s hydrogen-filled capillary at the upstream front end. This sharply increases the density of electrons in the subsequent plasma. The plasma density then falls off rapidly downstream.

A laser plasma accelerator uses a laser pulse (red and blue disks, extreme right) to create a wake through a plasma, creating strong electric fields. Like surfers on a wave, free electrons ride the wake and are accelerated to high energies. Only the electron bunch propelled by the first wave (white glow) is shown in this simulation. (Simulation by Jean-Luc Vay and Cameron Geddes)

“The extra density itself serves as a lens to focus the laser to higher intensity, and the laser is focused right where the extra density is beginning to decrease,” says Leemans. Here at the edge of the “density downramp,” the slower waves trap electrons more readily. “The waves in the wake are falling farther behind the laser pulse as it enters the region of lower density.”

Density control is only one way to control wave velocity, however. Another method is through laser intensity – an unexpected gift from Albert Einstein’s Special Theory of Relativity. Leemans explains, “The particles in the plasma waves have slowed because of the increased density, but they’re still moving relativistically, near the speed of light,”

Carl Schroeder, a theoretician with LOASIS and an author of the Nature Physics paper, says that “as the laser is focused, its intensity increases, driving larger and larger plasma waves.  Larger waves increase the relativistic mass effect. This reduces the frequency of the wave and stretches the wavelength. The peaks of the waves fall even farther behind the laser pulse.”

Says experimenter Tony Gonsalves, first author of the Nature Physics paper, “If we simply end the plasma there, we have a stable low-energy accelerator. But with a second stage we can accelerate the electron beam to much higher energy, and we can tune that energy.”

The same drive-laser pulse whose wake has been slowed by plasma density and laser intensity now powers into the low-density region of the accelerator; the following waves, carrying their extra load of electron “surfers,” rapidly catch up.

“Tuning the energy is possible because by changing the density or location of the higher-density plasma, we can change its focusing power, the intensity of the laser pulse, and how much the pulse spreads out in the following lower-density plasma,” Gonsalves says. “This allows us to tune the acceleration length and the final beam energy. The stability we achieve over our tunable range is quite amazing.”

By tailoring plasma density in the two zones over the length of the accelerator, the LOASIS researchers were able to tune the energy of the electron beams over a range from 100 million electron volts to 400 million electron volts, while maintaining energy stability to within a few percent.

Leemans says, “Tailoring plasma density longitudinally this way is a concept that shows a new path to the level of sophisticated tuning for accelerators and light sources that users of conventional facilities just take for granted. It’s a major step toward perfecting the laser plasma light sources and accelerators of the future.”

- Paul Preuss

Guest author

No Comments »